A Method to Monitor mRNA Levels in Human Breast Tumor Cells Obtained by Fine-needle Aspiration
Open Access
- 1 December 1997
- journal article
- research article
- Published by Wolters Kluwer Health in Diagnostic Molecular Pathology
- Vol. 6 (6) , 353-360
- https://doi.org/10.1097/00019606-199712000-00008
Abstract
A method based on the reverse transcriptase-polymerase chain reaction (RT-PCR) was developed that allows the determination of relative mRNA expression levels in fine-needle aspirates from human tumors. The method was developed for the c-erbB-2 gene, using the porphobilinogen deaminase (PBGD) gene as an internal standard. It was validated for mRNA isolated from cell lines and for material obtained by fine-needle aspiration from human breast cancer. Gene expression levels were determined by measuring the activity of radiolabeled RT-PCR-amplified gene-specific bands with a phosphor imager. At least four points are measured on the log-linear part of the amplification cycle versus signal intensity curves, and subsequently the distance between the curves of the gene of interest and that of an internal standard gene is used to calculate the relative expression levels. The method worked equally well with the BRCA1 gene, illustrating that it can be generalized to other genes. The method is suitable to measure or monitor semiquantitively gene expression levels in accessible human tumors in situ.Keywords
This publication has 11 references indexed in Scilit:
- Growth arrest associated changes of mRNA levels in breast cancer cells measured by semi-quantitative RT-PCR: potential early indicators of treatment responseCancer Letters, 1995
- Possible mechanisms in the emergence of tamoxifen-resistant breast cancerAnti-Cancer Drugs, 1995
- Multidrug resistance is more than MDR1 activityLeukemia Research, 1995
- The mechanisms of DNA topoisomerasesTrends in Biochemical Sciences, 1995
- A Strong Candidate for the Breast and Ovarian Cancer Susceptibility Gene BRCA1Science, 1994
- Prognostic factors observed in current clinical trialsCancer, 1993
- Antineoplastic drug resistance and DNA repairAnnals of Oncology, 1991
- Use of the polymerase chain reaction in the quantitation of MDR-1 gene expressionBiochemistry, 1990
- Tissue‐specific expression of porphobilinogen deaminaseEuropean Journal of Biochemistry, 1987
- Tyrosine Kinase Receptor with Extensive Homology to EGF Receptor Shares Chromosomal Location with neu OncogeneScience, 1985